Adrian  Van Bakel  to  Double-Blind Method
                            
                            
                                This is a "connection" page, showing publications  Adrian  Van Bakel  has written about  Double-Blind Method.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.038
         
        
        
     
 
    
        
        - 
            A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction. Eur J Heart Fail. 2017 10; 19(10):1321-1332.
            
            
                Score: 0.026
            
         
        
        - 
            Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med. 2005 Jun 30; 352(26):2705-13.
            
            
                Score: 0.011